Zymeworks (ZYME) Cash from Operations Growth (1y) (2022 - 2026)
Zymeworks (ZYME) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 356.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -1,241.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,241.88% |
| Dec 31, 2025 | 75.29% |
| Sep 30, 2025 | -434.22% |
| Jun 30, 2025 | 148.31% |
| Mar 31, 2025 | 90.96% |
| Dec 31, 2024 | -397.93% |
| Sep 30, 2024 | 86.22% |
| Jun 30, 2024 | -290.58% |
| Mar 31, 2024 | 54.71% |
| Dec 31, 2023 | -95.74% |
| Sep 30, 2023 | 41.56% |
| Jun 30, 2023 | 88.33% |
| Mar 31, 2023 | -50.13% |
| Dec 31, 2022 | 748.12% |